Canadian pharmaceutical company Scythian Biosciences Corp. named Michael Barnes to be chief medical officer.
Barnes, a clinical neurologist, is an honorary professor of neurological rehabilitation at the University of Newcastle.
Discover more about S&P Global’s offerings